Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study

• Main Authors: Lee, P., Kim, C.E., Kim, C.Y., Lin, W. W., Habil, H., Dyachkova, Y., McBride, M., Dossenbach, M.
• Format: Article
• Published: 2008
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/11046/; http://informahealthcare.com/doi/abs/10.1080/13651500801976634

Objective. To compare the effectiveness of olanzapine, risperidone, quetiapine, or haloperidol monotherapy in patients with schizophrenia who were treated in routine clinical practice settings for a period of 2 years. The incidence and persistence of adverse events encountered during long-term thera...